Madison Avenue Partners, LP Selecta Biosciences Inc Transaction History

Madison Avenue Partners, LP

  • $812 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 16, 2024
SELL
$0.67 - $1.35 $2.3 Million - $4.62 Million
-3,425,416 Reduced 85.46%
582,603 $401,000
Q3 2023

Nov 14, 2023
BUY
$1.02 - $1.23 $4.09 Million - $4.93 Million
4,008,019 New
4,008,019 $4.25 Million

Others Institutions Holding SELB

# of Institutions
5
Shares Held
4.67M
Call Options Held
0
Put Options Held
0
View Full List

About SELECTA BIOSCIENCES INC

SELB Quotes by TradingView
  • Ticker SELB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 152,712,992
  • Market Cap $128M
  • Description
  • Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. I...
More about SELB
Track This Portfolio

Track Madison Avenue Partners, LP Portfolio

Follow Madison Avenue Partners, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Madison Avenue Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Madison Avenue Partners, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email